Translational Imaging in Drug Discovery and Development
Translational Imaging in Drug Discovery and Development
Northeastern University,
Raytheon Amphitheater,
Egan Research Center,
360 Huntington Avenue
Boston, MA 02115
USA
Symposium program (8am - 5pm)
Opening Remarks: Mark Nedelman, President and CEO, EKAM Imaging
Morning Session Chair: Jack Hoppin, PhD, Co-Founder and Managing Partner, inviCRO, LLC
Breakfast
Morning Keynote Speech: “Medical Imaging in Discovery and Translational Research”, Matt Silva, PhD, Director of Research Imaging Sciences, Amgen
“Mechanistic Modeling and Molecular Imaging in Developing Targeted Therapeutics and Imaging Biomarkers”, Kelly Orcutt, PhD, Director of Translational Imaging, inviCRO, LLC
“Pre-clinical Imaging of Targeted Drug Delivery with SPECT/CT”, Steve Mather, PhD, Professor Emeritus, University of London
Break
“Preclinical Molecular Imaging of Tumor-Targeting Antibodies and Imaging Biomarker Candidates”, Daniel Bradley, PhD, Head, Biomedical Imaging Group and Sr. Scientist II, Millennium Pharmaceuticals
“ Multimodal Imaging Strategies in Neuroscience Drug Development”, Ajay Verma, MD, PhD, Vice-President of Translational Neurology and Neurodegeneration ,Biogen Idec
“Exploring the impact and opportunities of preclinical imaging technology in neurodegenerative disease and cancer drug development”, Paul McCracken, PhD, Director of Imaging, Eisai Pharmaceuticals
Lunch Break
Afternoon Session Chair: Mat Brevard, MS, National MRI Manager, BrukerBiospin
Afternoon Keynote Speech: “Integrating Imaging Modalities for Enhanced Drug Development”, Gerry Fox, PhD, Director, Translational Sciences, Abbott Laboratories
“Imaging as a Robust, Quantitative, Medium-Throughput Assay”, Jeffery Tsao, PhD, MBA, Associate Director, Clinical Research, Translational Imaging, Novartis Institutes for BioMedical Research
“Accelerating Cancer Drug Discovery Using Imaging” ,Andrew L. Kung, M.D., Ph.D., Director, Lurie Family Imaging Center, Dana-Farber Cancer Institute
Break
“Animal Model of Presymptomatic Parkinson’s Disease” , Craig Ferris, PhD, Professor, Psychology and Pharmaceutical Sciences, Director, Center for Translational NeuroImaging, Northeastern University
Panel Discussion Moderator: Tony McCook, VP North American Sales, Bioscan Inc.
Participants:
Mark Meadowcroft, PhD, Bristol-Myers Squibb
Matt Silva, PhD, Amgen
Gerry Fox, PhD, Abbott
Craig Ferris, PhD, NEU
Steve Mather, PhD, Professor Emeritus, University of London
Register for free (until September,15th)
http://www.imagingsymposium.com
or contact us at +1 617 933 8730 / info@imagingsymposium.com
[Download Agenda]